Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: A systematic review and meta-analysis
Open Access
- 1 June 2018
- journal article
- review article
- Published by Elsevier in International Journal of Cardiology
- Vol. 261, 84-91
Abstract
No abstract availableKeywords
Funding Information
- Biotronik
- Medtronic
- Boehringer Ingelheim
This publication has 23 references indexed in Scilit:
- Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: Findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryAmerican Heart Journal, 2014
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsThe Lancet, 2014
- Restarting Anticoagulation and Outcomes After Major Gastrointestinal Bleeding in Atrial FibrillationThe American Journal of Cardiology, 2014
- Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studiesEP Europace, 2013
- Risk of Thromboembolism, Recurrent Hemorrhage, and Death After Warfarin Therapy Interruption for Gastrointestinal Tract BleedingArchives of internal medicine (1960), 2012
- A New Risk Scheme to Predict Warfarin-Associated HemorrhageJACC, 2011
- Bleeding risk assessment and management in atrial fibrillation patientsThrombosis and Haemostasis, 2011
- Optimal Timing of Resumption of Warfarin After Intracranial HemorrhageStroke, 2010
- A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial FibrillationChest, 2010
- Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)American Heart Journal, 2006